DOCSLIB.ORG

Scientific Tracks & Abstracts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Scientific Tracks & Abstracts conferenceseries.com 985th Conference 18th Annual Cardiologists Conference June 19-21, 2017 Paris, France Scientific Tracks & Abstracts Day 1 Cardiologists 2017 Page 31 Oral Sessions Day 1 June 19, 2017 Cardiac Regeneration|Heart Disease| Electrocardiography | Cardiomyopathies | Diabetes & Heart | Cardiac Nursing Session Chair Session Co-chair Guy Hugues Fontaine William E. Feeman Jr. La Salpêtrière Hospital, France Wood County Hospital, USA Session Introduction Enhanced prediction of the population at risk of atherothrombotic disease Title: William E Feeman Jr., Wood County Hospital, USA Genetic ventricular arrhythmia: Clinical presentation and disease modeling using iPSC- Title: derived cardiomyocytes Katriina Aalto-Setala, University of Tampere & Tampere University Hospital, Finland Cardiologists 2017 Page 32 William E Feeman Jr., J Clin Exp Cardiolog 2017, 8:6(Suppl) conferenceseries.com DOI: 10.4172/2155-9880-C1-071 18th Annual Cardiologists Conference June 19-21, 2017 Paris, France Enhanced prediction of the population at risk of atherothrombotic disease William E Feeman Jr. Wood County Hospital, USA Statement of the Problem: To be able to prevent atherothrombotic disease (ATD), one must be able to predict the population at risk of ATD. Many risk predictors have been advocated for such prediction, but none have been universally accepted. Methodology & Theoretical Orientation: The Framingham Heart Study has demonstrated that the population that develops ATD differs from the population that does not by the severity of certain ATD risk factors and the duration during which those risk factors have been operative. The author has examined his entire ATD population to determine the constellation of ATD risk factors that separates population from the population that did not develop some form of clinical ATD. Findings: The population at risk of ATD is characterized by cigarette smoking, dyslipidemia, and (often) hypertension, with some contribution from the very high blood sugar levels of uncontrolled diabetes. These risk factors are not independent, but rather dependent, interacting with one another leading to ATD. Dyslipidemia is defined as a ratio between LDL- and HDL-cholesterol (Cholesterol Retention Fraction, or CRF, defined as [LDL-HDL]/LDL). The predictive tool is a graph with the CRF on the ordinate and systolic blood pressure (SBP) on the abscissa. The graph exhibits a threshold line with CRF-SBP co-ordinates (0.74, 100) and (0.49, 140), above which lie the CRF-SBP of 93% of all the ATD patients in the author’s practice. The outcomes of those patients can be found in the Table. Further fine-tuning can be done by stratifying the CRF by SBP or by LDL-cholesterol. Any therapy that brings the CRF-SBP plot below the threshold line results in plaque stabilization/regression in a minimum average of 75% of cases. Conclusions: The population at risk of ATD is predictable and hence, ATD is preventable. Biography William E Feeman Jr is a Physician at Wood County Hospital, and private practice in Bowling Green, Ohio. He is the Founder of Association for the Prevention of Atherothrombotic Disease in Northwest Ohio to facilitate the spread of knowledge about this disease. bgs43402@yahoo.com J Clin Exp Cardiolog, an open access journal Cardiologists 2017 Volume 8, Issue 6 (Suppl) ISSN: 2155-9880 June 19-21, 2017 Page 33 Katriina Aalto-Setälä, J Clin Exp Cardiolog 2017, 8:6(Suppl) conferenceseries.com DOI: 10.4172/2155-9880-C1-071 18th Annual Cardiologists Conference June 19-21, 2017 Paris, France Genetic ventricular arrhythmia: Clinical presentation and disease modeling using iPSC-derived cardiomyocytes Katriina Aalto-Setälä1, 2 1University of Tampere, Finland 2Tampere University Hospital, Finland Background & Aim: Genetic cardiac arrhythmias are often severe, but due to their rare nature, no specific treatment exists. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe arrhythmia caused by mutations in the RyR2 gene. This gene is important in regulating Ca2+ release from sarcoplasmic reticulum. The purpose of this study was to create induced pluripotent stem cells (iPSCs) from individuals having CPVT and to study the functional properties of the cardiomyocytes. Methodology: iPSC lines were derived from six individuals carrying different RyR2 gene mutations. Arrhythmias of cardiomyocytes were analyzed using Ca2+ imaging. Findings: Patients’ heart rates were increased by stress exercise test and this induced in all of them polymorphic ventricular extra beats. When their cardiomyocytes were treated with adrenaline, similar irregular beating was observed. If the patients were treated with dantrolene, in some individuals all arrhythmias were abolished, but in some, it did not have any effect. As their cardiomyocytes were treated with the same drug, adrenaline-induced arrhythmias were abolished, but only from those cardiomyocytes derived from individuals who also clinically responded to the treatment. However, arrhythmias were not abolished from cardiomyocytes derived from the patients having no response to the medication. Conclusion & Significance: With this drug, we could demonstrate that all individuals did not respond to this medication the same way even though their clinical phenotype was the same and they had mutations in the same gene. Importantly, iPSC-derived cardiomyocytes demonstrated the very same phenomenon: If the patient responded, also his cardiomyocytes responded, but if the drug did not remove arrhythmias from the patient, they were not abolished from his cardiomyocytes either. This study demonstrate that iPSC-derived cells reproduce the effect observed in the patients and they could be used to tailor medication especially in patients having severe, potentially lethal arrhythmias. Biography Katriina Aalto-Setala is the Professor of Physiology at School of Medicine, University of Tampere and a Cardiologist at Heart Hospital, Tampere University Hospital, Finland. She works as an invasive Cardiologist and is In-charge of the genetic cardiac outpatient clinic at Heart Hospital. Her research at University of Tampere focuses on Human Genetic Cardiac Diseases such as genetic arrhythmias and atherosclerosis with the help of induced pluripotent stem cell (iPSC) technology. The main aim of the research group is to learn more about the basic pathology of the genetic diseases as well as to test current and new pharmaceutical agents to correct the abnormalities. Her research group in collaboration with researches at Tampere Technical University has also invented new methods to monitor and analyze the maturity and functionality cardiomyocytes. katriina.aalto-setala@uta.fi Notes: J Clin Exp Cardiolog, an open access journal Cardiologists 2017 Volume 8, Issue 6 (Suppl) ISSN: 2155-9880 June 19-21, 2017 Page 34 conferenceseries.com 985th Conference 18th Annual Cardiologists Conference June 19-21, 2017 Paris, France Special Session Day 1 Cardiologists 2017 Page 36 Fabiola B Sozzi, J Clin Exp Cardiolog 2017, 8:6(Suppl) conferenceseries.com DOI: 10.4172/2155-9880-C1-071 18th Annual Cardiologists Conference June 19-21, 2017 Paris, France Fabiola B Sozzi University Hospital Policlinico of Milan, Italy Diastolic stress echocardiography: How and when to perform it here is growing evidence that the diastolic stress test can provide important diagnostic findings helpful in the management of patients presenting with dyspnea of an unclear etiology. Many patients present with exertional dyspnea and exercise Tintolerance, but have normal left ventricular filling pressures at rest. In these patients, it is important to evaluate filling pressure with exercise. Exercise can be performed using a supine bicycle or treadmill protocol. Alternatively dobutamine can be used, though its vasodilator as well as inotrope effect determine a very different hemodynamic response compared to that of exercise. We need to record mitral inflow by pulsed Doppler echocardiography at the level of the mitral tips, mitral annular velocities by spectral Doppler echocardiography, and tricuspid regurgitation jet by continuous-wave Doppler at baseline and after the termination of exercise. Diastolic function parameters can be obtained soon after the assessment of regional wall motion abnormalities, especially when an exercise echocardiogram is performed for the evaluation of dyspnea. In patients with diastolic heart failure, left atrial pressure is increased, leading to an increase in mitral E velocity, whereas annular e’ velocity remains reduced given the limited preload effect on e’. Moreover, an increase in the pulmonary artery systolic pressure can be detected by the increase in peak velocity of the tricuspid regurgitation jet. On the other hand, in the absence of cardiac disease, e’ increases to a similar extent to the increase in mitral E velocity, and the normal E/e’ ratio essentially is unchanged with exercise. The concept of the diastolic stress test was introduced more than 10 years ago. Subsequently, exercise E/e’ ratio was validated against invasive measurements. Importantly, exercise septal E/e’ ratio was an important determinant of exercise capacity, and its decline with age was noted in a large series of patients referred for exercise echocardiography. Furthermore, a recent study showed the incremental prognostic value of exercise E/e’ ratio over clinical variables and exercise wall motion score index. In conclusion, diastolic stress test has an interesting role in patients with heart failure and preserved ejection fraction that present
Load more

Recommended publications
  • Cardiologists Conference June 11-13, 2018 | Barcelona, Spain
    Fabiola B Sozzi, Int J Cardiovasc Res 2018, Volume 7 conferenceseries.com DOI: 10.4172/2324-8602-C1-005 24th Annual Cardiologists Conference June 11-13, 2018 | Barcelona, Spain Echocardiographic diagnosis of diastolic heart failure Fabiola B Sozzi Ospedale Maggiore Policlinico Cà Granda, Italy hronic dyspnea is associated with a variety of diseases and is also a major symptom of heart failure (HF). The differential Cdiagnosis of dyspnea is a daily routine in every cardiology practice. Approximately one-half of patients with HF have a preserved ejection fraction (HFpEF). Diagnosis of HFpEF is challenging and relies largely on demonstration of elevated cardiac filling pressures represented by the pulmonary capillary wedge pressure (1). Healthy individuals with normal relaxation are able to increase the rate of myocardial relaxation when there is a need for increased diastolic filling. Faster relaxation allows the achievement of a lower minimal left ventricular (LV) diastolic pressure at a shorter time interval than in the resting state. Hence, increased LV filling can occur even with a shortened diastolic filling time. When myocardial relaxation is reduced in the resting state, it cannot be increased as much as necessary to meet the demands of exertion or stress. In this situation with abnormal myocardial relaxation, a reduced diastolic filling period and a lack of atrial contraction compromise LV filling substantially, causing the increase in left atrial and LV diastolic pressures (hence, decreased diastolic reserve). Collectively, there is growing evidence that the diastolic stress test can provide important diagnostic findings that can be helpful in the management of patients presenting with dyspnea of an unclear etiology (2).
    [Show full text]
  • Longitudinal Analysis of Gait Performance
    Accepted Manuscript Donor-site morbidity following osteocutaneous free fibula transfer: longitudinal analysis of gait performance Riccardo Di Giuli, MD, Matteo Zago, PhD, Giada A. Beltramini, MD, Maria Ludovica Pallotta, MD, Alessandro Bolzoni, MD, Alessandro Baj, MD, Aldo Bruno Giannì, MD, Chiarella Sforza, MD PII: S0278-2391(18)31195-9 DOI: https://doi.org/10.1016/j.joms.2018.10.016 Reference: YJOMS 58502 To appear in: Journal of Oral and Maxillofacial Surgery Received Date: 5 October 2018 Revised Date: 20 October 2018 Accepted Date: 25 October 2018 Please cite this article as: Di Giuli R, Zago M, Beltramini GA, Pallotta ML, Bolzoni A, Baj A, Giannì AB, Sforza C, Donor-site morbidity following osteocutaneous free fibula transfer: longitudinal analysis of gait performance, Journal of Oral and Maxillofacial Surgery (2018), doi: https://doi.org/10.1016/ j.joms.2018.10.016. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. provided by AIR Universita degli studi di Milano View metadata, citation and similar papers at core.ac.uk CORE brought to you by ACCEPTED MANUSCRIPT Donor-site morbidity following osteocutaneous free fibula transfer: longitudinal analysis of gait performance. Riccardo Di Giuli, MD *,§, Matteo Zago, PhD *,#, Giada A.
    [Show full text]
  • Dr Tommaso Mauri
    Dr Tommaso Mauri Specialty: Anesthesia and Critical Care Institute: Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan Department: Anesthesia, Critical Care and Emergency City: Milan Country: Italy Function: Assistant professor and staff physician Key words: ARDS, respiratory physiology, mechanical ventilation, monitoring. Short signature CV Dr Mauri graduated from the University of Milan-Bicocca in 2004 with a degree thesis on the role of acute inflammation in ARDS. He then entered the residency program from the same university between 2005 and 2008. Dr Mauri spent 14 months as research fellow at the Dept. of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, USA, between 2007 and 2008. After becoming board certified anesthesiologist and intensivist, he joined as staff and researcher the Dept. of c of the San Gerardo Hospital and University of Milan-Bicocca, Monza, Italy from 2008 to 2014, under the direction of Prof. A. Pesenti. From October 2014 on, Dr. Mauri moved to be assistant professor and staff physician in the general ICU of the Dept. of Anesthesia and Critical Care of the University of Milan - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Italy, under the direction of Prof. L. Gattinoni and, after his retirement, Prof. A. Pesenti. Dr Mauri published more than 60 articles in international peer reviewed journals on respiratory physiology, ARDS, ECMO, mechanical ventilation, high flow nasal cannula support, advanced respiratory monitoring, esophageal pressure and electrical impedance tomography applications, cardiac arrest, infections. Since 2011, Dr Mauri gave more than 80 invited talks in national and international critical care congresses.
    [Show full text]
  • BMI) and Severity of Depressive Symptoms on Biological Changes of Women Affected by Overweight/Obesity
    International Journal of Environmental Research and Public Health Article The Independent Role of Body Mass Index (BMI) and Severity of Depressive Symptoms on Biological Changes of Women Affected by Overweight/Obesity Simona Iodice 1, Alessandro Ceresa 2,*, Cecilia Maria Esposito 2 , Francesco Mucci 2, Diana Misaela Conti 3, Laura Pergoli 1, Letizia Tarantini 1, Luisella Vigna 3 , Valentina Bollati 1 , Massimiliano Buoli 2,4 , Marta Serati 5 and Stand-Up Project Group † 1 EPIGET LAB, Department of Clinical Sciences and Community Health, University of Milan, Via San Barnaba 8, 20122 Milan, Italy; simona.iodice@unimi.it (S.I.); laura.pergoli@unimi.it (L.P.); letizia.tarantini@unimi.it (L.T.); valentina.bollati@unimi.it (V.B.) 2 Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy; cecilia.esposito@unimi.it (C.M.E.); francesco.mucci@unimi.it (F.M.); massimiliano.buoli@unimi.it (M.B.) 3 Occupational Health Unit, Center of Obesity and Work EASO Collaborating Centers for Obesity Management, Fondazione Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; diana.misaela@gmail.com (D.M.C.); luisella.vigna@policlinico.mi.it (L.V.) 4 Department of Neurosciences and Mental Health, Fondazione IRCSS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy 5 Department of Mental Health, ASST Rhodense, 20024 Rho, Italy; martaserati@libero.it * Correspondence: alessandro.ceresa@unimi.it; Tel.: +39-02-55035983 † The members of the Stand-Up Project Group are acknowledged at the end of the article. Citation: Iodice, S.; Ceresa, A.; Esposito, C.M.; Mucci, F.; Conti, D.M.; Pergoli, L.; Tarantini, L.; Vigna, L.; Abstract: Background: Both obesity and depression are medical conditions associated with severe Bollati, V.; Buoli, M.; et al.
    [Show full text]
  • An International Registry of Patients with Plasminogen Deficiency
    REVIEW ARTICLE An international registry of patients with Ferrata Storti Foundation plasminogen deficiency (HISTORY) Amy D. Shapiro, 1 Marzia Menegatti, 2 Roberta Palla, 3 Marco Boscarino, 2 Christopher Roberson, 1 Paolo Lanzi, 4 Joel Bowen, 5 Charles Nakar, 1 Isaac A. Janson 1 and Flora Peyvandi 2,3 1Indiana Hemophilia & Thrombosis Center, Indianapolis, IN, USA; 2Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy; 3Università degli Studi di Haematologica 2020 4 Milano, Department of Pathophysiology and Transplantation, Milan, Italy; Misto s.r.l., Volume 105(3):554-561 Milan, Italy and 5Rho, Inc., Durham, NC, USA ABSTRACT lasminogen deficiency is an ultra-rare multisystem disorder charac - terized by the development of fibrin-rich pseudomembranes on Pmucous membranes. Ligneous conjunctivitis, which can result in vision impairment or loss, is the most frequent symptom reported. Affected systems may also include the respiratory tract, oropharynx, female reproductive tract, gingiva, middle ear, renal collecting system, skin and central nervous system. Untreated, plasminogen deficiency may result in significant reduction in quality of life and morbidity with poten - tial life-threatening complications. Non-specific therapies are inadequate and plasminogen concentrates are not commercially available. The cur - rent understanding of plasminogen deficiency and management of disease symptoms and its progression are based on case reports/series and two small clinical trials. To date there has never been a comprehensive, inter - national study to examine the natural history or optimal therapeutic inter - Correspondence: vention; knowledge gaps include identification of contributing factors and triggers of disease manifestations, inability to predict disease course, and AMY D.
    [Show full text]
  • Three Months of COVID-19 in a Pediatric Setting in the Center of Milan
    www.nature.com/pr INSIGHTS Three months of COVID-19 in a pediatric setting in the center of Milan Carlo Agostoni1,2, Giuseppe Bertolozzi1, Barbara Cantoni1,3, Carla Colombo1,2, Giovanni Montini1,2 and Paola Marchisio1,2 The second epicenter of the global COVID-19 epidemic following Wuhan, and the first in the Western world, occurred unexpectedly in the Lombardy region of Italy, whose capital city is Milan. The aggressive nature of the outbreak in the region was dramatic, leading to a 2-month period of lockdown. Within the Policlinico, the historic hospital in the center of Milan, many units were rapidly converted into intensive care units or semi-intensive units for adult patients. During lockdown, the pediatric inpatient units had to face daily reorganization caused by the necessary logistic and structural transformations, thus restricting routine care pathways for chronic patients, while the Pediatric Emergency Unit had to develop a system able to effectively separate the children and caregivers infected with COVID-19 from those who were not affected. These 2 months enhanced resilience among both doctors and nurses, and facilitated the transversal transmission of data aimed at helping colleagues and patients in any way possible, in spite of the restrictive measures limiting the rate of activity in pediatric care. The reorganization of the current phase of decreasing epidemic activity still leaves us with unanswered questions regarding the further possible changes to implement in the event of a potential reoccurrence of epidemic peaks. Pediatric Research (2021) 89:1572–1577; https://doi.org/10.1038/s41390-020-01108-8 1234567890();,: INTRODUCTION: FOCUS ON THE CONTEXT cold and deserted during those days.
    [Show full text]
  • Proteome Investigation of Rat Lungs Subjected to Ex Vivo Perfusion (EVLP)
    molecules Article Proteome Investigation of Rat Lungs Subjected to Ex Vivo Perfusion (EVLP) Valentina Roffia 1,2,† , Antonella De Palma 2,† , Caterina Lonati 3 , Dario Di Silvestre 2 , Rossana Rossi 2 , Marco Mantero 4, Stefano Gatti 1, Daniele Dondossola 5, Franco Valenza 6, Pierluigi Mauri 2,* and Francesco Blasi 4 1 Center for Preclinical Research, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy; valentina.roffia@itb.cnr.it (V.R.); stefano.gatti@policlinico.mi.it (S.G.) 2 Proteomics and Metabolomics Unit, Institute for Biomedical Technologies (ITB-CNR), 20090 Segrate (MI), Italy; antonella.depalma@itb.cnr.it (A.D.P.); dario.disilvestre@itb.cnr.it (D.D.S.); rossana.rossi@itb.cnr.it (R.R.) 3 Department of Anesthesia and Critical Care, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; caterina.lonati@gmail.com 4 Department of Pathophysiology and Transplantation, Università degli Studi di Milano, and Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy; marco.mantero@unimi.it (M.M.); francesco.blasi@unimi.it (F.B.) 5 Surgery and Liver Transplant Center, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy; dondossola.daniele@gmail.com 6 Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy; franco.valenza@unimi.it * Correspondence: pierluigi.mauri@itb.cnr.it; Tel.: +39-02-2642-2736 † These authors contributed equally to this work. Received: 15 September 2018; Accepted: 21 November 2018; Published: 22 November 2018 Abstract: Ex vivo lung perfusion (EVLP) is an emerging procedure that allows organ preservation, assessment and reconditioning, increasing the number of marginal donor lungs for transplantation.
    [Show full text]
  • Relevance of Vitamin D Deficiency in Patients
    Massironi et al. BMC Gastroenterology (2018) 18:172 https://doi.org/10.1186/s12876-018-0901-0 RESEARCHARTICLE Open Access Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study Sara Massironi1, Federica Cavalcoli1,2*, Alessandra Zilli1,2, Alessandro Del Gobbo3, Clorinda Ciafardini1, Susanna Bernasconi1, Irene Felicetta4, Dario Conte1 and Maddalena Peracchi1 Abstract Background: Chronic autoimmune atrophic gastritis (CAAG) is an autoimmune disease characterized by hypo /achlorhydria. A role of CAAG in the pathogenesis of nutritional deficiencies has been reported, therefore we hypothesized a possible association between CAAG and 25-OH-Vitamin D [25(OH)D] deficiency. Aim of the present study is to evaluate the prevalence of 25(OH)D deficiency in CAAG patients. Methods: 87 CAAG patients (71 females; mean age 63.5 ± 12.8 years) followed at our Centre from January 2012 to July 2015 were consecutively evaluated. 25(OH)D, vitamin B12, parathormone, and calcium were measured in all the CAAG patients. The results were compared with a control group of 1232 healthy subjects. Results: In the CAAG group the mean 25(OH)D levels were significantly lower than in the control group (18.8 vs. 27.0 ng/ ml, p < 0.0001). 25(OH)D levels < 20 ng/ml was observed in 57 patients, while levels < 12.5 ng/ml in 27 patients. A significant correlation between vitamin B12 values at diagnosis and 25(OH)D levels was observed (rs =0.25,p = 0.01). Interestingly, the CAAG patients with moderate/severe gastric atrophy had lower25(OH)Dvaluesascomparedtothosewithmildatrophy (11.8 vs.
    [Show full text]
  • Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4
    ORIGINAL RESEARCH published: 29 April 2020 doi: 10.3389/fneur.2020.00255 Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4 Serena Pagliarani 1*, Sabrina Lucchiari 1, Marina Scarlato 2, Elisa Redaelli 3, Anna Modoni 4, Francesca Magri 5, Barbara Fossati 6, Stefano C. Previtali 2, Valeria A. Sansone 7, Marzia Lecchi 8, Mauro Lo Monaco 4,9, Giovanni Meola 6 and Giacomo P. Comi 1,10 1 Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy, 2 Department of Neurology and INSPE, IRCCS Ospedale San Raffaele, Milan, Italy, 3 Department of Biotechnology and Biosciences, University of Milano - Bicocca, Milan, Italy, 4 Institute of Neurology, Area of Neuroscience, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy, 5 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy, 6 Department of Neurorehabilitation Sciences, casa di Cura del Policlinico, Milan, Italy, 7 Neurorehabilitation Unit, University of Milan; The NEMO (NEuroMuscular Omniservice) Clinical Center, Milan, Italy, 8 Department of Biotechnology and Biosciences and Milan Center for Neuroscience, University of Milano - Bicocca, Milan, Italy, 9 MIA (Myotonics in Association), Portici, Italy, 10 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neuromuscular and Rare Diseases Unit, Milan, Italy Sodium channel myotonia is a form of muscle channelopathy due to mutations that affect the Nav1.4 channel. We describe seven families with a series of symptoms ranging Edited by: from asymptomatic to clearly myotonic signs that have in common two novel mutations, Jean-François Desaphy, p.Ile215Thr and p.Gly241Val, in the first domain of the Nav1.4 channel.
    [Show full text]
  • Lung Donation After Circulatory Death
    10 Review Article Page 1 of 10 Lung donation after circulatory death Valeria Musso1,2, Ilaria Righi1, Francesco Damarco1, Alessandra Mazzucco1,2, Alberto Zanella2,3, Luigi Vivona2, Alessandro Palleschi1,2 1Thoracic Surgery and Lung Transplantation Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico of Milan, Milan, Italy; 2Università degli Studi di Milano, Milan, Italy; 3Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico of Milan, Milan, Italy Contributions: (I) Conception and design: A Palleschi, V Musso; (II) Administrative support: A Palleschi; (III) Provision of study materials or patients: A Palleschi, V Musso, F Damarco, A Zanella; (IV) Collection and assembly of data: A Palleschi, V Musso, F Damarco, A Mazzucco, L Vivona; (V) Data analysis and interpretation: A Palleschi, V Musso, I Righi; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Valeria Musso. Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico of Milan, Via Francesco Sforza 35, Milan, Italy. Email: valeria.musso@unimi.it. Abstract: Donation after circulatory death (DCD) defines organs procurement after death determined using circulatory criteria, as opposed to a declaration based on neurological criteria. Nowadays, DCD donors represent a valuable resource to contrast lung donor shortage and waiting list mortality, while also avoiding the potential lung damages generated by brain death. On the other hand, lungs from DCD donors are exposed to a variable warm ischemia time and related potential detrimental effects. The extensive experimental investigation proved the feasibility of this practice, and the subsequent clinical experiences around the world showed good outcomes. In this paper, we review the pre-clinical and clinical experiences in the DCD field, focusing on ischemia time and the biological peculiarities of the lung tissue in animal models.
    [Show full text]
  • Influence of Biochemical Diagnosis of Growth Hormone Deficiency On
    www.nature.com/scientificreports OPEN Infuence of biochemical diagnosis of growth hormone defciency on replacement therapy response and retesting results at adult height Giulia Rodari 1,2*, E. Profa2, F. Giacchetti2, I. Cavenaghi2, M. Arosio1,2 & C. Giavoli1,2 Isolated growth hormone defciency (IGHD) is the most frequent endocrinological disorder in children with short stature, however the diagnosis is still controversial due to the scarcity of reliable diagnostic criteria and pre-treatment predictive factors of long term-response. To evaluate recombinant growth hormone (rGH) long-term response and retesting results in three diferent groups of children divided in accordance with the biochemical criteria of initial diagnosis. Height gain (∆HT) at adult height (AH) and retesting results were evaluated in 57 rGH treated children (M = 34, 59.6%) divided into 3 groups according to initial diagnosis: Group A (n = 25) with max GH peak at stimulation test < 8 µg/L, Group B (n = 19) between 8 and 10 µg/L and Group C (n = 13) with mean overnight GH < 3 µg/L (neurosecretory dysfunction, NSD). Retesting was carried out in all patients after at least one month of therapy upon reaching the AH. 40/57 (70.2%) patients were pre-pubertal at diagnosis and showed ∆HT of 1.37 ± 1.00 SDS, with no signifcant diferences between groups (P = 0.08). Nonetheless, 46% patients in Group B showed ∆HT < 1SDS (vs 13% and 12% in Group A and C, respectively) and 25% children failed to reach mid-parental height (vs 6% and 0% in Group A and C, respectively). At AH attainment, IGHD was reconfrmed in 28% (7/25) and 10% (2/19) in Group A and B, respectively.
    [Show full text]
  • The Ospedale Maggiore - Policlinico of Milan
    The Ospedale Maggiore - Policlinico of Milan Michele Augusto Riva, Daniele Mazzoleni University of Milano Bicocca, via Cadore 48, 20900, Monza Riva MA, Mazzoleni D. The Ospedale Maggiore Policlinico of Milan. J Med Pers 2012 Mar 14. DOI: 10.1007/s12682-012-0116-z The “Ospedale Maggiore” of Milan, traditionally known as “Ca’ Granda”, is one of the most ancient hospitals in Italy, being founded by the Duke Francesco Sforza (1401-1466) in 1456. The aims of the hospital were to provide free medical assistance for the poorest people of the city and to improve efficiency in healthcare by converging patients from the various institutions of Milan on a single “bigger” structure (“Domus Magna Hospitalis”). The initial building project was signed by the Renaissance architect Antonio di Pietro Averlino, known as Filarete (c. 1400-1469), but only the southern portion of the building was executed from his design. Indeed in 1465 Filarete was succeeded in his office of architect by Guiniforte Solari (c. 1429-1481) who was followed in his turn by Giovanni Antonio Amadeo (c. 1447-1522) [1]. The hospital consisted of a square with buildings running through in the form of a cross (crociera ). Each wing of the cross was reserved for a specific disease, and at the junction of the four arms of the crociera stood the chapel, so arranged for allowing patients to participate in the daily celebration of the Eucharistic rite. According to the Renaissance reform of hospitals promoted by the Milanese archbishop Enrico Rampini (1390- 1450), only people suffering from acute diseases could be admitted to the structure, while chronic and “incurable” diseases (e.g.
    [Show full text]